FR2398499A1 - Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine - Google Patents

Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine

Info

Publication number
FR2398499A1
FR2398499A1 FR7821943A FR7821943A FR2398499A1 FR 2398499 A1 FR2398499 A1 FR 2398499A1 FR 7821943 A FR7821943 A FR 7821943A FR 7821943 A FR7821943 A FR 7821943A FR 2398499 A1 FR2398499 A1 FR 2398499A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
prolactin
secretion
inhibit
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821943A
Other languages
English (en)
Other versions
FR2398499B1 (fr
Inventor
Francis E Harrington
Ronald G Babington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/904,191 external-priority patent/US4202897A/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2398499A1 publication Critical patent/FR2398499A1/fr
Application granted granted Critical
Publication of FR2398499B1 publication Critical patent/FR2398499B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Abstract

L'invention a pour objet des compositions pharmaceutiques pour inhiber la sécrétion de la prolactine. Selon l'invention ces compositions pharmaceutiques contiennent un composé répondant à la formule :
FR7821943A 1977-07-25 1978-07-25 Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine Granted FR2398499A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81842077A 1977-07-25 1977-07-25
US86236677A 1977-12-20 1977-12-20
US89129978A 1978-03-29 1978-03-29
US05/904,191 US4202897A (en) 1977-07-25 1978-05-11 Prolactin secretion inhibitors

Publications (2)

Publication Number Publication Date
FR2398499A1 true FR2398499A1 (fr) 1979-02-23
FR2398499B1 FR2398499B1 (fr) 1981-02-06

Family

ID=27505854

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821943A Granted FR2398499A1 (fr) 1977-07-25 1978-07-25 Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine

Country Status (9)

Country Link
JP (1) JPS5444032A (fr)
AU (1) AU3829978A (fr)
DE (1) DE2830610A1 (fr)
FR (1) FR2398499A1 (fr)
GB (1) GB2001531A (fr)
IL (1) IL55208A0 (fr)
IT (1) IT7850363A0 (fr)
NL (1) NL7807804A (fr)
PH (1) PH15001A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2412311A1 (fr) * 1977-12-20 1979-07-20 Sandoz Sa Nouvelles compositions pharmaceutiques a base d'un derive de l'imidazole

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215261B (it) * 1985-04-05 1990-01-31 Poli Ind Chimica Spa Composizioni farmaceutiche adattivita' antigalattopoietica.
TWI461426B (zh) * 2009-05-27 2014-11-21 Merck Sharp & Dohme （二氫）咪唑並異〔５，１－ａ〕喹啉類

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2163865A1 (de) * 1970-12-24 1972-07-20 Sandoz Ag, Basel (Schweiz) Hypolipämisches Mittel
FR2255907A1 (en) * 1974-01-02 1975-07-25 Sandoz Sa 5-Phenyl-tetrahydro-imidazo (2,1-A)isoquinolin-5-ol derivs - prepd. by reacting 2-(2-imidazolin-2-yl)-benzyl-lithium cpds. with benzoic acid derivs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2163865A1 (de) * 1970-12-24 1972-07-20 Sandoz Ag, Basel (Schweiz) Hypolipämisches Mittel
FR2255907A1 (en) * 1974-01-02 1975-07-25 Sandoz Sa 5-Phenyl-tetrahydro-imidazo (2,1-A)isoquinolin-5-ol derivs - prepd. by reacting 2-(2-imidazolin-2-yl)-benzyl-lithium cpds. with benzoic acid derivs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2412311A1 (fr) * 1977-12-20 1979-07-20 Sandoz Sa Nouvelles compositions pharmaceutiques a base d'un derive de l'imidazole

Also Published As

Publication number Publication date
PH15001A (en) 1982-03-22
JPS5444032A (en) 1979-04-07
IT7850363A0 (it) 1978-07-19
AU3829978A (en) 1980-01-31
DE2830610A1 (de) 1979-02-08
FR2398499B1 (fr) 1981-02-06
GB2001531A (en) 1979-02-07
IL55208A0 (en) 1978-09-29
NL7807804A (nl) 1979-01-29

Similar Documents

Publication Publication Date Title
FR2372219A1 (fr) Compositions anti-solaires
FR2371454A1 (fr) Nouvelles compositions pharmaceutiques a base d'alcaloides peptidiques de l'ergot de seigle
BG60249B2 (en) Thiazole compound for treatment of ulcers
FR2379255A1 (fr) Agents fongicides
FR2361340A1 (fr) Nouvelles anilines substituees utilisables comme medicament
FR2386521A1 (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
DK607783D0 (da) Nitroaliphatiske forbindelser
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
FR2375239A1 (fr) Derives d'acide 7-amino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique
FR2404009A1 (fr) 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques
FR2398499A1 (fr) Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine
FR2361326A1 (fr) Derives de cyclohexane utiles comme agents odoriferants
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
IL100955A (en) Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
ES368955A1 (es) Procedimiento para preparar guanidinas sustituidas
FR2401167A1 (fr) Derives de thienothiazine utiles comme medicaments
FR2377997A1 (fr) Aralcoylanilines utilisables comme medicament
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
FR2374313A1 (fr) Compose a cycle triazole utilisable comme medicament
FR2416223A1 (fr) Derives de phenylpyrol utilisables comme fongicides
FR2368957A1 (fr) Compositions a base de sels quaternaires de promethazine
FR2446636A1 (fr) Nouvelles compositions pharmaceutiques a base d'une benzo(c) (1,6)naphtyridine

Legal Events

Date Code Title Description
ST Notification of lapse